Effectiveness of Brief Intervention in Primary Care for Diverse Young People (Chat)
Launched by RAND · Nov 18, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Effectiveness of Brief Intervention in Primary Care for Diverse Young People," is studying a short counseling program designed to help teenagers aged 12 to 17 who may be at risk of using alcohol or cannabis. The program uses a method called motivational interviewing, which is a friendly conversation technique that encourages young people to think about their choices and make healthier decisions. The trial is currently looking for participants who receive healthcare at specific locations and who show signs of being at risk for substance use.
To be eligible for the study, teenagers must be between 12 and 17 years old and must have a positive screening result indicating they might be at risk for drinking alcohol or using cannabis. If a young person does not meet these criteria, they will not be able to participate. If chosen for the trial, participants can expect to engage in a brief intervention with a healthcare provider, which will help them discuss their habits in a safe and supportive environment. This trial is important because it aims to find effective ways to support young people in making healthier choices regarding substance use.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • receive health care at one of two participating health systems
- • aged 12-17
- • screen positive for being at risk for alcohol or cannabis use using the CRAFFT
- Exclusion Criteria:
- • if they don't meet the inclusion criteria, they will be excluded
About Rand
RAND is a leading nonprofit research organization dedicated to improving policy and decision-making through rigorous analysis and evidence-based solutions. With a commitment to advancing public health, RAND conducts innovative clinical trials that aim to evaluate new treatments, interventions, and health policies. By leveraging multidisciplinary expertise and a collaborative approach, RAND strives to translate research findings into actionable insights that enhance healthcare outcomes and inform stakeholders across the medical and policy landscapes. Through its comprehensive studies, RAND plays a pivotal role in shaping the future of health and wellness on a global scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Commerce, California, United States
Pittsburgh, Pennsylvania, United States
Patients applied
Trial Officials
Elizabeth J. D'Amico, PhD
Principal Investigator
RAND
Alina I Palimaru, PhD
Principal Investigator
RAND
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported